Validated GC–MS analysis for the determination of residual fentanyl in applied Durogesic® reservoir and Durogesic® D-Trans® matrix transdermal fentanyl patches - ScienceDirect

Validated GC–MS analysis for the determination of residual fentanyl in applied Durogesic® reservoir and Durogesic® D-Trans® matrix transdermal fentanyl patches - ScienceDirect

Development and evaluation of a tampering resistant transdermal fentanyl patch - ScienceDirect

Predicting transdermal fentanyl delivery using physics-based simulations for tailored therapy

FENTANYL TRANSDERMAL SYSTEM 25 mcg/hr, 50 mcg/hr, 75 mcg/hr, 100 mcg/hr CII Full Prescribing Information Rx only FOR USE IN OPIOID-TOLERANT PATIENTS ONLY

Fentanyl Transdermal Matrix Patch (Durotep® MT Patch; Durogesic® DTrans®; Durogesic® SMAT)

Identification of volatile components in the headspace of pharmaceutical-grade fentanyl - ScienceDirect

Transdermal Matrix Fentanyl Membrane Patch (Matrifen®)

Frontiers Predicting Transdermal Fentanyl Delivery Using Mechanistic Simulations for Tailored Therapy

Validation of a Fentanyl Transdermal Adhesion Scoring Tool for Use in Clinical Practice - ScienceDirect

Exploring the thermally-controlled fentanyl transdermal therapy to provide constant drug delivery by physics-based digital twins